Whether your early phase development strategy is to establish proof of concept or rapid progression into Phase III trials, Pharmatek will customize the development plan to establish a strong foundation for your compound’s long-term success.

From preclinical toxicology formulation development and accelerated early phase development programs to Clinical Trial Materials (CTM) supply and scale-up, Pharmatek offers complete formulation and analytical expertise for small molecules and peptides. We offer the range of characterization and preformulation services to truly understand your drug substance, develop effective formulations and manufacture processes, and generate the data to enable IND filings. Our data-driven approach provides customers with best in class CMC development strategies that get you quickly to the clinic while reducing costs and building asset value.

Have Questions For A Pharmatek Representative?

Contact Us